Algorithme Pharma announces Christopher Perkin as President and Chief Executive Officer

Laval, Wednesday, May 12, 2010 – Doug Peel, Executive Chairman of the Board of Directors of Algorithme Pharma, is pleased to announce the appointment of Christopher Perkin as the company’s President and Chief Executive Officer.  Mr. Perkin will officially join the company on May 31st.

This important appointment confirms Algorithme Pharma’s commitment to the development of innovative strategies to better serve its clients and business partners.  It also reflects the company’s on-going efforts to become a world leader in clinical research and bioanalysis.

A native of England with a solid scientific background, Christopher Perkin is a seasoned executive and recognized leader with more than 30 years’ experience in pharmaceutical development and business strategy.  After holding several key positions at Huntingdon Research Center and Beecham Pharmaceuticals, Mr. Perkin joined the Charles River Laboratories in Senneville, Quebec, Canada, where he rose through the ranks to Corporate Senior Vice President – Global Preclinical Services with responsibility for operations in Asia and North America.

 “Mr. Perkin is a highly talented individual with world-class experience in our industry, and I am confident he will create a dynamic environment with a renewed business focus that will reinforce our industry-leading position and assure our status as a key international partner of pharmaceutical companies,” said Doug Peel, Executive Chairman of the Board of Algorithme Pharma Holdings Inc.